SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYPH - Cytoclonal Pharmaceutics -- Ignore unavailable to you. Want to Upgrade?


To: Sir Auric Goldfinger who wrote (403)1/28/2000 12:57:00 PM
From: RockyBalboa  Respond to of 428
 
Junk....

I enjoy a backdoor effect....RRRR, nice.



To: Sir Auric Goldfinger who wrote (403)1/28/2000 8:35:00 PM
From: RockyBalboa  Respond to of 428
 
Old news, but still good:

Tuesday January 25, 8:00 am Eastern Time

Cytoclonal Launches Website - www.cytoclonal.com

DALLAS, Jan. 25 /PRNewswire/ -- Cytoclonal Pharmaceutics Inc. (Nasdaq: CYPH - news, CYPHW - news, CYPHZ - news), today announced the launch of its new website at ht tp://www.cytoclonal.com.

''Today's sophisticated investor desires current news on a company's latest developments; the Internet has become one of the major means of providing that,'' said Arthur P. Bollon, Ph.D., Chairman and CEO. ''We are pleased to launch our website as we move into the next century and what promises to be an exciting era for biotechnology.''

Cytoclonal.com includes the Company's profile, business strategy and a history of developments through a library of press releases. Also included is an overview of Cytoclonal programs including Taxol®, drug design Quantum Core Technology(TM), and its human genome technologies. Financial information including corporate data, Securities and Exchange filings, and the up-to-the-minute share price are also available.

....

biz.yahoo.com